Late-Stage Studies Star at ASCO 2015
Another ASCO annual meeting has come and gone, and now comes the fun part where we digest and interpret the significance of the mountains of new data presented.
ASCO 2015: Immuno-Oncology Again Takes Center Stage
The ASCO annual meeting has retained its core purpose of providing a unique platform for oncologists to interact and exchange the latest practice-changing research.
Tracing the Path of Prostate Cancer Spread
The past decade has demonstrated a movement toward more extensive LND in order to sample and remove more lymph nodes.
Impairment-Driven Cancer Rehabilitation Improves Survivors' Quality of Life
The lack of comprehensive rehabilitation services is a profound source of unnecessary suffering for survivors.
A Promising Move Toward Compassionate Access to Drugs
Dr. Andre Goy discusses efforts to improve "compassionate use" programs that expand access to promising drugs that are not yet approved by the FDA.
Dr Phillips on the Treatment Landscape for Patients With MCL
Dr Chari on the Bridging the Gaps in Hematologic Malignancies Meeting
Dr Danilov on Addressing Unmet Needs in Hematologic Malignancies
Dr Saeed on the Use of Pola-R-CHP in Previously Untreated DLBCL
2 Commerce Drive Cranbury, NJ 08512